Cambridge, MA, United States of America

Ke Liu

This inventor holds 2 USPTO granted patents. Top assignees: Harvard College, The Board Institute, Inc., The Broad Institute, Inc.. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ke Liu. Retrieved from https://idiyas.com/inventor/ke-liu-14k4c3pi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Ke Liu

Introduction

Ke Liu is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of medical research. With a total of two patents to his name, Liu's work focuses on the treatment of isocitrate dehydrogenase-related diseases. His innovative approach has the potential to impact the lives of many patients suffering from these conditions.

Latest Patents

Liu's latest patents include compounds and methods for the treatment of isocitrate dehydrogenase-related diseases. The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester, or prodrug thereof. This groundbreaking work aims to provide new therapeutic options for patients affected by these diseases.

Career Highlights

Throughout his career, Ke Liu has worked with prestigious institutions such as Harvard College and The Broad Institute, Inc. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research.

Collaborations

Some of Liu's notable coworkers include Mahmud Hussain and Daisuke Ito. Their collaborative efforts have further advanced the research and development of innovative treatments in the medical field.

Conclusion

In summary, Ke Liu is an accomplished inventor whose work in the treatment of isocitrate dehydrogenase-related diseases showcases his dedication to improving healthcare. His patents and collaborations reflect his commitment to innovation and the betterment of patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…